8-KItem 2.01 · Acquisition/DispositionItem 7.01 · Reg FD DisclosureItem 8.01 · Other EventsItem 9.01 · Financial Statements
ALBEMARLE CORP (ALB)

Albemarle completed sale of 51% of Ketjen to ChemCat AcquisitionCo (KPS affiliate) on Mar 2, 2026;…

Filed with the SEC on · Summarized by InvestorsBot

Albemarle completed sale of 51% of Ketjen to ChemCat AcquisitionCo (KPS affiliate) on Mar 2, 2026; Albemarle retains a 49% minority stake. $ALB 🤝📅 #M&A #Chemicals

Albemarle expects ~ $547M cash from the Ketjen sale (incl. $22M cash at close). Combined with Jan 2026 Eurecat sale to Axens, total pre-tax proceeds ≈ $670M. $ALB 💵📈 #PrivateEquity #CapitalAllocation

Albemarle will retain 100% of Ketjen’s Performance Catalyst Solutions business, now integrated into Albemarle’s product portfolio — keeps catalyst exposure while monetizing a controlling interest. $ALB 🔧➡️🏢 #Strategy #Catalysts

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from ALBEMARLE CORP

Albemarle appoints former Vale CEO Eduardo Bartolomeo to its board

8-K · July 23, 2026

Albemarle appoints former Vale CEO Eduardo Bartolomeo to its board

8-K · July 23, 2026

ALB files Third Amendment to Credit Agreement (Exhibit 10.1) dated Mar 19, 2026 — borrowers: Albemarle…

8-K · March 25, 2026

BREAKING: Albemarle ($ALB) inks 3rd amendment to its 2022 credit agreement — extends loan maturity to Oct…

8-K · March 25, 2026

Albemarle ($ALB) Item 9.01: Filed exhibits include Stock Purchase Agreement among Albemarle, Ketjen Corp &…

8-K · March 6, 2026

On Mar 2, 2026 Albemarle ($ALB) announced the redemption of its 4.650% Senior Notes due 2027.

8-K · March 6, 2026